Clinical Trial Update: Clinical Application Study of [123I]Metaiodobenzylguanidine and Somatostatin Receptor-Targeted Imaging in the Diagnosis and Staging of Neuroblastoma

View source ↗

Summary

This clinical trial update describes an imaging-based diagnostic study using [123I]Metaiodobenzylguanidine and somatostatin receptor-targeted imaging for diagno…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Drugs mentioned

• Somatostatin receptor-targeted imaging agent (somatostatin receptor imaging agent)
• [123I]Metaiodobenzylguanidine (metaiodobenzylguanidine)

Snippet

Sponsor: Nanjing First Hospital, Nanjing Medical University | Conditions: Neuroblastoma (NB) | Status: RECRUITING